TELA Bio

TELA on Nasdaq. Market value $37m.

Watch this stockFree. We tell you when something changes.

Should I look at this?

Look carefully before going further

Why it could be worth it

Nothing stands out yet.

Read the warning sign in its own filings

This is not advice.

Compare with another stock

Who owns it

None of the long-term investors we follow own it. 45 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

9 investors own more than 5%.

  • EW Healthcare Partners Fund 2 GP, L.P.
    Passive investor
    at least 17.3%
    (filed with 2 related holders)
    Since 17 November 2025
  • EW Healthcare Partners Fund 2-GP, L.P.
    at least 17.2%+10.4 pts
    (filed with 3 related holders)
    Since 9 June 2026
    What they said

    The disclosure set forth in Item 6 below is hereby incorporated by reference in this Item 4. This Schedule 13D reports that, on June 9, 2026, an operating partner affiliated with the Reporting Persons was appointed to the Board of Directors of the Issuer. Except as described…

    Read the filing
  • at least 14.5%+1.6 pts
    (filed with 2 related holders)
    Since 30 September 2026
  • North Run Capital, LP
    Passive investor
    at least 7.8%−1.5 pts
    (filed with 6 related holders)
    Since 30 September 2026
  • Devesh S. Gandhi
    Passive investor
    7.8%
    Since 31 December 2024
  • Lytton, Laurence W.
    Passive investor
    5.5%−1.7 pts
    Since 31 March 2026
  • at least 4.8%0.0 pts
    (filed with 1 related holder)
    Since 30 June 2026
  • Orin Hirschman
    Passive investor
    at least 3.6%−3.2 pts
    (filed with 1 related holder)
    Since 31 March 2025
  • GROW FUNDS, LLC.
    Passive investor
    n/a
    Since 30 September 2025
  • Sold down below 5%
    Since 30 September 2026

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 2 insiders bought $186,016 of shares on the open market.

  • Capper Joseph H
    Director
    Bought
    Date
    17 September 2026
    Shares
    25,000
    Price
    $1.22
    Value
    $30,530
  • Capper Joseph H
    Director
    Bought
    Date
    16 September 2026
    Shares
    50,000
    Price
    $1.17
    Value
    $58,265
  • Capper Joseph H
    Director
    Bought
    Date
    15 September 2026
    Shares
    50,000
    Price
    $1.06
    Value
    $52,940
  • Capper Joseph H
    Director
    Bought
    Date
    14 September 2026
    Shares
    25,000
    Price
    $1.02
    Value
    $25,503
  • Getz Heather C
    Chief Executive Officer, Director
    Bought
    Date
    17 August 2026
    Shares
    12,500
    Price
    $0.66
    Value
    $8,311
  • Getz Heather C
    Chief Executive Officer, Director
    Bought
    Date
    14 August 2026
    Shares
    15,000
    Price
    $0.70
    Value
    $10,467

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

1 serious warning sign in TELA Bio’s filings.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 25 Mar 2026, plus the 10-Q filed 10 Nov 2026 and 12 later 8-Ks.

  • Doubt it can keep going

    Serious

    The company or its auditor warned it may not have enough money to last the next year.

    “These conditions and events raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”

    From the 10-Q filed 10 November 2026, Part I, Item 1. Financial Statements. Read it in the filing

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.